Kodiak Sciences Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
KOD Nasdaq 2836 kodiak.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Kodiak Sciences Inc.

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 - Aug 6th, 2026 5:00 am
Kodiak CFO Sells $1 Million in Stock as Shares Surge 650%. What Investors Should Know - Jun 9th, 2026 6:04 pm
Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans - Jun 6th, 2026 7:18 am
Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know - Jun 4th, 2026 9:05 am
Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference - May 28th, 2026 4:09 pm
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase - May 17th, 2026 2:46 pm
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally - May 17th, 2026 2:17 pm
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares - May 17th, 2026 2:07 pm
A Look At Kodiak Sciences (KOD) Valuation After Positive Phase 3 GLOW2 Results For Zenkuda - May 10th, 2026 7:14 pm
Zenkuda Phase 3 Win and Expanding Pipeline Might Change The Case For Investing In Kodiak Sciences (KOD) - May 10th, 2026 1:09 pm
Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus - May 8th, 2026 10:39 am
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results - May 7th, 2026 2:00 pm
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences - Apr 30th, 2026 10:23 pm
Kodiak Sciences (KOD) Up 2% Since Last Earnings Report: Can It Continue? - Apr 30th, 2026 9:30 am
Kodiak Sciences Inc (KOD): What’s the Chance of Success for Zenkuda? - Apr 23rd, 2026 3:47 am
Eagle Eye Solutions Group Leads The Charge In UK Penny Stocks - Apr 13th, 2026 8:05 am
Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05) - Apr 12th, 2026 3:18 pm
Kodiak Sciences GLOW2 Win Puts Zenkuda And Funding Needs In Focus - Apr 7th, 2026 7:09 am
Assessing Kodiak Sciences (KOD) Valuation After Recent Share Price Momentum And Conflicting Signals - Apr 6th, 2026 7:19 pm
Sector Update: Health Care Stocks Higher Late Afternoon - Apr 1st, 2026 1:57 pm